# CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC

> **NCT07383246** · PHASE3 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 150 (estimated)

## Conditions studied

- Medullary Thyroid Carcinoma

## Interventions

- **PROCEDURE:** 68Ga-CTR-FAPI PET-CT guided surgery
- **PROCEDURE:** investigator choice of surgery

## Key facts

- **NCT ID:** NCT07383246
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-25
- **Primary completion:** 2028-09-01
- **Final completion:** 2031-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07383246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07383246, "CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07383246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*